Biovian is in the news about pandemic vaccine manufacturing possibilities
The leading regional newspaper of of the Southwest Finland interviewed Knut Ringbom, the CEO of Biovian about the COVID-19 vaccine manufacturing possibilities.
“Pandemic vaccine manufacturing is a hot topic. We have been contacted by European vaccine developers concerning vaccine production. Biovian is very interested in vaccine manufacturing opportunities. As a contract development and manufacturing organization, CDMO we first need to agree the details of the program with the license owner.”
Link to the article (for subscribers, in Finnish). https://www.ts.fi/uutiset/talous/5290911/Turkulainen+Biovian+voisi+valmistaa+pandemiarokotteita++Meihin+on+oltu+yhteydessa+rokotetuotannon+tiimoilta+niin+Suomesta+kuin+Euroopasta
